ReviewNanomedicine (London, England)2025
Smart magnetic nanoparticles under electromagnetic stimulation: a synergistic approach to targeted chemotherapy and hyperthermia.
Review in Nanomedicine (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Electromagnetic stimulated magnetic nanoparticles (MNPs) have emerged as a promising multifunctional platform for disease treatment, particularly in oncology. While magnetic hyperthermia and nanoparticle-mediated drug delivery have been extensively studied, they are often explored as separate modalities, overlooking the substantial synergistic effects achievable when combined, especially under electromagnetic stimulation. Recent studies reveal that integrating magnetic hyperthermia with electromagnetic stimulated drug delivery enhances spatial and temporal therapeutic precision and significantly increases cancer cell apoptosis, outperforming either approach alone. Despite growing evidence supporting this dual-function strategy, the literature lacks a comprehensive evaluation of the underlying mechanisms, therapeutic outcomes, and translational challenges associated with electrostimulated MNPs. This review addresses that gap by critically examining the dual role of electrostimulated MNPs in delivering localized heat and controlled drug release. We further explore innovative strategies to overcome clinical limitations such as tissue penetration and targeting depth. This review also summarizes recent synthetic methods and functionalization strategies for magnetic nanoparticles, evaluates their effectiveness in electromagnetic stimulated drug release and hyperthermia, and discusses clinical translation barriers. Through this integrated perspective, we aim to advance the understanding and application of electromagnetic stimulated MNPs as a breakthrough approach in cancer therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.